Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Anna Sala-Cunill"'
Autor:
Johana Gil-Serrano, Moisés Labrador-Horrillo, Paula Galvan-Blasco, Anna Sala-Cunill, Patricia Bigas, Javier Pereira-González, Olga Luengo, Victoria Cardona, Mar Guilarte
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundHereditary angioedema (HAE) is a rare disease characterized by localized and self-limited angioedema (AE) attacks. A local increase of bradykinin (BK) mediates AE attacks in HAE, however the role of inflammation in HAE has been poorly explo
Externí odkaz:
https://doaj.org/article/b3679c17342c4e6199c8e7c3f390efd8
Autor:
Gustavo-Jorge Molina-Molina, MD, Manuel Gómez-Duque, MD, Xavier Vidal Guitart, MD, PhD, Antònia Agustí Escasany, MD, PhD, Moisés Labrador-Horrillo, MD, PhD, Olga Luengo, MD, PhD, Anna Sala-Cunill, Paula Galvan-Blasco, MD, Mar Guilarte, MD, PhD, Victoria Cardona, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 6, Pp 100914- (2024)
Background: Drug provocation tests (DPT) are considered the gold standard procedure to ascertain the diagnosis of beta-lactam (BL) allergy. Regarding route of administration, current recommendations prioritize oral challenges, considering them safer,
Externí odkaz:
https://doaj.org/article/e3a02a31a0cc4f0a81fa3f4e4c8b44e7
Autor:
Markus Magerl, Anna Sala‐Cunill, Christina Weber‐Chrysochoou, Susanne Trainotti, Ilaria Mormile, Giuseppe Spadaro
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Abstract Hereditary angioedema (HAE) is a rare autosomal dominant disease, with patients often suffering with associated symptoms for many years before receiving a correct diagnosis. The symptoms greatly impact a patient's quality of life (QoL) and i
Externí odkaz:
https://doaj.org/article/787d70489ded4d93bb87a68614a36bd3
Autor:
Mar Guilarte, Anna Sala-Cunill, María Luisa Baeza, Rosario Cabañas, María Dolores Hernández, Ethel Ibañez, Carlos Hernando de Larramendi, Ramon Lleonart, Teófilo Lobera, Luis Marqués, Blanca Sáenz de San Pedro, Jaco Botha, Irmgard Andresen, Teresa Caballero, for the IOS Study Group
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-11 (2021)
Abstract Background The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B2 receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to assess
Externí odkaz:
https://doaj.org/article/90ff5c111ba24797ac5c9aba507fb7be
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Anaphylaxis is the most severe form of allergic reaction, resulting from the effect of mediators and chemotactic substances released by activated cells. Mast cells and basophils are considered key players in IgE-mediated human anaphylaxis. Beyond IgE
Externí odkaz:
https://doaj.org/article/010ca36888024111a4c9d5d38950054f
Autor:
Gemma, Melé-Ninot, Esther, Serra-Baldrich, Jorge, Spertino, Mar, Guilarte, Paula, Ribó González, Ramon, Lleonart-Bellfill, Ignasi, Figueras-Nart, Montserrat, Bonfill-Ortí, Nathalie, Depreux, Anna, Sala-Cunill, Isabel, Bielsa-Marsol, Carola, Baliu-Piqué, Verònica, Sanmartín-Novell, Xavier, Garcia-Navarro, Vicente, Expósito-Serrano, Diana, Garnica-Velandia, Maria Carmen, Diaz-Sarrió, Sara, Gómez-Armayones, Ignasi, Gich Saladich, Ana, Giménez-Arnau
Publikováno v:
European journal of dermatology : EJD. 32(5)
The guidelines for the treatment of chronic spontaneous urticaria (CSU) recommend adding omalizumab to the treatment of patients with uncontrolled disease despite four-fold doses of second-generation antihistamines (AH). On the contrary, some studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa8089480e6f20549f471ea7efd635c3
https://pubmed.ncbi.nlm.nih.gov/36468733
https://pubmed.ncbi.nlm.nih.gov/36468733
Autor:
Nuria Rodríguez-Garijo, Marina Sabaté-Brescó, Julián Azofra, Maria Luisa Baeza, Camen Diaz Donado, Pere Gaig, Mar Guilarte, Valeria Herrera-Lasso, Moisés Labrador-Horrillo, Anna Sala-Cunill, Beatriz Veleiro, Maria Pilar Gil, Marta Ferrer
Publikováno v:
Scientia
Histamine-mediated angioedema is the most frequent form of angioedema. It is classified as idiopathic histaminergic acquired angioedema (IH-AAE)1 when allergies and other causes have been excluded and a positive treatment response to antihistamines,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9610308e7a4da7460515db20a6623c7b
https://hdl.handle.net/11351/8645
https://hdl.handle.net/11351/8645
Autor:
Jorge Pamias-Romero, Joan Masnou-Pratdesaba, Manel Sáez-Barba, Alba de-Pablo-García-Cuenca, Sahyly Siurana-Montilva, Anna Sala-Cunill, Victòria Valls-Comamala, Rosa Pujol-Pina, Coro Bescós-Atín
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 16; Pages: 4791
Scientia
Scientia
Personalized surgery; Tertiary hospital; Virtual planning Cirugía personalizada; Hospital terciario; Planificación virtual Cirurgia personalitzada; Hospital terciari; Planificació virtual Personalized surgery (PS) involves virtual planning (VP) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35bbe7330d4f4667bf006cc71b183c83
Autor:
Victoria Cardona, Anna Sala-Cunill, Moises Labrador-Horrillo, Adrian Curran, Nuria Moreno, Mónica Gonzalez-Medina, Olga Luengo, Paula Galvan-Blasco, Mar Guilarte
Publikováno v:
Allergy. 76:1507-1516
BACKGROUND Epinephrine is the first-line treatment for anaphylaxis. Patients at risk should always carry an epinephrine autoinjector (EAI). Several EAI gaps have been identified. We sought to evaluate satisfaction using a medical device (digital tech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890e268a697dded1fde60905eb73ab63
https://doi.org/10.1111/all.14626
https://doi.org/10.1111/all.14626
Autor:
José L Pérez-Formoso, José A Álvarez-Fernández, Carla Torán-Barona, Juan A Martínez-Tadeo, Anna Boronat-Barado, José L Justicia, Juan J Linana-Santafé, Ignacio Garcia-Nunez, Zulay Almeida-Sanchez, Anna Sala-Cunill
Publikováno v:
Immunotherapy. 12:1007-1019
Aim: To assess the safety and effectiveness of an allergen immunotherapy (AIT) with a microcrystalline tyrosine-associated mite allergoid in real-world patients with allergic rhinitis (AR). Materials & methods: Retrospective, multicenter study assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b84c21fbdbca3ce267665257e6eb470
https://doi.org/10.2217/imt-2020-0194
https://doi.org/10.2217/imt-2020-0194